101 related articles for article (PubMed ID: 21880832)
1. An ACE inhibitor improves vascular outcomes in a PKD model.
Nauli SM
Am J Physiol Renal Physiol; 2011 Nov; 301(5):F958. PubMed ID: 21880832
[No Abstract] [Full Text] [Related]
2. Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease.
Ng K; Hildreth CM; Avolio AP; Phillips JK
Am J Physiol Renal Physiol; 2011 Nov; 301(5):F959-66. PubMed ID: 21865263
[TBL] [Abstract][Full Text] [Related]
3. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats.
Yamada K; Horita T; Takayama M; Takahashi S; Takaba K; Nagata Y; Suzuki N; Kanda T
Brain Res; 2011 Nov; 1421():110-20. PubMed ID: 21981801
[TBL] [Abstract][Full Text] [Related]
4. [Bradykinin and cardiovascular protection. Role of perindopril, an inhibitor of angiotensin conversion enzyme].
Lancellotti P; Ancion A; D'Orio V; Gach O; Maréchal P; Krzesinski JM
Rev Med Liege; 2018 Apr; 73(4):197-205. PubMed ID: 29676873
[TBL] [Abstract][Full Text] [Related]
5. [Principles of choice of an angiotensin-converting enzyme inhibitor: specific features of perindopril].
Morozova TE; Gontarenko SV; Kuz'mina EP
Ter Arkh; 2014; 86(9):115-8. PubMed ID: 25518516
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
Cressman AM; Macdonald EM; Fernandes KA; Gomes T; Paterson JM; Mamdani MM; Juurlink DN;
Br J Clin Pharmacol; 2015 Oct; 80(4):662-9. PubMed ID: 25980448
[TBL] [Abstract][Full Text] [Related]
7. The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Brugts JJ; de Maat MP; Boersma E; Witteman JC; van Duijn C; Uitterlinden AG; Bertrand M; Remme W; Fox K; Ferrari R; Danser AH; Simoons ML;
Cardiovasc Drugs Ther; 2009 Apr; 23(2):171-81. PubMed ID: 19082699
[TBL] [Abstract][Full Text] [Related]
8. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke.
Hatazawa J; Shimosegawa E; Osaki Y; Ibaraki M; Oku N; Hasegawa S; Nagata K; Hirata Y; Miura Y
Stroke; 2004 Sep; 35(9):2117-22. PubMed ID: 15256675
[TBL] [Abstract][Full Text] [Related]
9. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
Dinicolantonio JJ; Lavie CJ; O'Keefe JH
Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903
[TBL] [Abstract][Full Text] [Related]
10. Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease.
Yamada K; Uchida S; Takahashi S; Takayama M; Nagata Y; Suzuki N; Shirakura S; Kanda T
Brain Res; 2010 Sep; 1352():176-86. PubMed ID: 20627092
[TBL] [Abstract][Full Text] [Related]
11. Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.
Gomez C; Berteina-Raboin S; De Nanteuil G; Guillaumet G
Bioorg Med Chem; 2013 Nov; 21(22):7216-21. PubMed ID: 24095015
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular outcomes and angiotensin converting enzyme inhibitors: beyond blood pressure control. Editorial to: "Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?" by Remme et al.
Verma A; Ventura HO
Cardiovasc Drugs Ther; 2009 Apr; 23(2):109-11. PubMed ID: 19005745
[No Abstract] [Full Text] [Related]
13. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.
Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
Int J Cancer; 2013 Sep; 133(5):1234-46. PubMed ID: 23436228
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction.
Qu Z; Xu H; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3410-7. PubMed ID: 26045879
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model.
Alsac JM; Journe C; Louedec L; Dai J; Julia P; Fabiani JN; Michel JB
Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):474-80. PubMed ID: 21256058
[TBL] [Abstract][Full Text] [Related]
16. Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock.
Wiel E; Pu Q; Leclerc J; Corseaux D; Bordet R; Lund N; Jude B; Vallet B
Intensive Care Med; 2004 Aug; 30(8):1652-9. PubMed ID: 15024568
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS
Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242
[TBL] [Abstract][Full Text] [Related]
18. [Perindopril arginin: novel drug form of a well known Angiotensin converting enzyme inhibitor].
Leonova MV
Kardiologiia; 2008; 48(10):65-70. PubMed ID: 18991838
[No Abstract] [Full Text] [Related]
19. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
Tropeano AI; Boutouyrie P; Pannier B; Joannides R; Balkestein E; Katsahian S; Laloux B; Thuillez C; Struijker-Boudier H; Laurent S
Hypertension; 2006 Jul; 48(1):80-6. PubMed ID: 16702490
[TBL] [Abstract][Full Text] [Related]
20. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril.
Jackson B; Cubela RB; Sakaguchi K; Johnston CI
Endocrinology; 1988 Jul; 123(1):50-5. PubMed ID: 2838262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
